Scarica l'app Stockscreener
4.27
2.89%
0.12
Dopo l'orario di chiusura:
4.32
0.05
+1.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$4.15
Aprire:
$4.18
Volume 24 ore:
3.80M
Relative Volume:
2.85
Capitalizzazione di mercato:
$1.66B
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
169.44
EPS:
0.0252
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-12.68%
1M Prestazione:
-38.21%
6M Prestazione:
-42.91%
1 anno Prestazione:
-18.36%
Intervallo 1D:
$4.16
$4.39
Intervallo di 1 settimana:
$4.09
$4.95
Portata 52W:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| GDRX | 4.27 | 1.66B | 775.09M | -58.68M | 64.06M | 0.0252 |
| VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
| HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
| TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
GoodRx (NASDAQ:GDRX) Sees Strong Trading VolumeHere's Why - MarketBeat
GoodRx (NASDAQ:GDRX) Shares Down 7.5%Here's Why - MarketBeat
Why GoodRx Holdings Stock Was Sinking This Week - AOL
AMERIPRISE FINANCIAL INC's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
Rubric Capital Management LP's Strategic Acquisition in GoodRx H - GuruFocus.com
GoodRx stock hits 52-week low at $4.66 amid market challenges - Investing.com India
Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm - PR Newswire
GOODRX ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Barclays Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Holdings Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Reviewing TELUS International (Cda) (NYSE:TIXT) & GoodRx (NASDAQ:GDRX) - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q3 2024 Earnings Call Transcript - Insider Monkey
Why GoodRx Holdings (GDRX) Stock is Moving Today - GuruFocus.com
Why GoodRx Holdings Stock Was Sinking This Week - The Motley Fool
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... - Yahoo Finance
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Call Highlights: Strong Financial Performance ... By GuruFocus - Investing.com Canada
GoodRx Holdings Reports Strong Q3 2024 Performance - TipRanks
GoodRx (GDRX) Q3 2024 Earnings Call Transcript - Yahoo Finance
GoodRx (NASDAQ:GDRX) Shares Down 13.9%Here's What Happened - MarketBeat
GoodRx Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
GoodRx Reports Third Quarter 2024 Results - BioSpace
GoodRx (GDRX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
GoodRx Holdings, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year 2024 - Marketscreener.com
GoodRx Holdings, Inc. (GDRX) Misses Q3 Earnings and Revenue Estimates - Yahoo Finance
GoodRx Q3 revenue misses estimates, lowers full-year outlook By Investing.com - Investing.com Canada
GoodRx Q3 revenue misses estimates, lowers full-year outlook - Investing.com
GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 1c ; Offers Guidance - StreetInsider.com
GoodRx (GDRX) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates - MSN
GoodRx accused of conspiring with PBMs over reimbursement fees - Seeking Alpha
GoodRx Holdings Inc (GDRX) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
GoodRx, PBMs Hit by Price Fixing Lawsuits - AJMC.com Managed Markets Network
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Purchased by Raymond James & Associates - MarketBeat
Vanguard Group Inc's Strategic Reduction in GoodRx Holdings Inc - GuruFocus.com
GoodRx, PBMs accused of suppressing reimbursements to independent pharmacies - Reuters
GoodRx to Participate in Upcoming Investor Conferences - StockTitan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
How To Trade (GDRX) - Stock Traders Daily
GoodRx Unveils New E-commerce Platform, Launches with Opill® - Quantisnow
GoodRx Unveils New E-commerce Platform, Launches with Opill® – Company Announcement - Financial Times
Assenagon Asset Management S.A. Decreases Stake in GoodRx Holdings, Inc. (NASDAQ:GDRX) - MarketBeat
GoodRx (GDRX) Scheduled to Post Quarterly Earnings on Thursday - MarketBeat
GoodRx (GDRX) Set to Announce Earnings on Thursday - Defense World
GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Shares May Have Run Too Fast Too Soon - Simply Wall St
GoodRx appoints IQVIA CFO to board for financial expertise - Investing.com India
GoodRx Holdings Strengthens Board with New Appointment - TipRanks
Ronald E. Bruehlman Joins GoodRx Board of Directors - Business Wire
GoodRx: The Tide Is Turning The Wrong Way (Rating Downgrade) (NASDAQ:GDRX) - Seeking Alpha
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus.com
GoodRx Announces New Affordability Programs for Menopause Hormone Therapies - Marketscreener.com
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.40%
0.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):